Armatus Bio
Armatus Bio is a biotechnology company developing next-generation vectorized RNAi therapeutics for neuromuscular diseases, specifically targeting the genetic cause of FSHD. Their lead program, ARM-201, aims to silence the expression of DUX4, the toxic protein responsible for muscle degeneration in individuals with FSHD. The company is focused on precision medicines to transform care for people with genetic neuromuscular disorders.
Funding Round: Strategic Investment
Funding Amount: $3M
Date: 06-May-2025
Investors: SOLVE FSHD
Markets: Biotech, Healthtech, Biopharma, Biotechnology, Health Diagnostics, Drug Discovery, Life Sciences
HQ: Columbus, Ohio, United States
Founded: 2020
Website: https://armatusbio.com
LinkedIn: https://www.linkedin.com/company/armatusbio
Crunchbase: https://www.crunchbase.com/organization/armatus-bio
Leave a Comment
Comments
No comments yet.